Expression of eag1 channel associated with the aggressive clinicopathological features and subtype of breast cancer.

about

Expression of eag1 channel associated with the aggressive clinicopathological features and subtype of breast cancer.

Item

http://www.wikidata.org/entity/Q36464823

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Expression of eag1 channel ass ...... and subtype of breast cancer.

@ast

Expression of eag1 channel ass ...... and subtype of breast cancer.

@en

type

Item

label

Expression of eag1 channel ass ...... and subtype of breast cancer.

@ast

Expression of eag1 channel ass ...... and subtype of breast cancer.

@en

prefLabel

Expression of eag1 channel ass ...... and subtype of breast cancer.

@ast

Expression of eag1 channel ass ...... and subtype of breast cancer.

@en

P1476

Expression of eag1 channel ass ...... and subtype of breast cancer.

@en

P2093

Fen Liu

http://www.w3.org/2001/XMLSchema#string

Guang-Xu Liu

http://www.w3.org/2001/XMLSchema#string

Sheng-Nan Ren

http://www.w3.org/2001/XMLSchema#string

Xiang-Ping He

http://www.w3.org/2001/XMLSchema#string

Xue-Dong Fang

http://www.w3.org/2001/XMLSchema#string

Yan He

http://www.w3.org/2001/XMLSchema#string

Yun-Cui Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Ether à go-go potassium channel expression in soft tissue sarcoma patients

Oncogenic potential of EAG K(+) channels

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

The potassium channel Ether à go-go is a novel prognostic factor with functional relevance in acute myeloid leukemia

Aberrant expression of ether à go-go potassium channel in colorectal cancer patients and cell lines.

A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer.

Ether a go-go potassium channels as human cervical cancer markers.

Role of lapatinib in the first-line treatment of patients with metastatic breast cancer.

The Eag potassium channel as a new prognostic marker in ovarian cancer.

A voltage-driven switch for ion-independent signaling by ether-à-go-go K+ channels.

P304

15093-15099

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26823849

http://www.w3.org/2001/XMLSchema#string

P932

4713635

http://www.w3.org/2001/XMLSchema#string